Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avricore Health (AVCRF) Share-based Compensation (IS) (2016 - 2025)

Historic Share-based Compensation (IS) for Avricore Health (AVCRF) over the last 11 years, with Q3 2025 value amounting to $37416.8.

  • Avricore Health's Share-based Compensation (IS) fell 8490.27% to $37416.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $297729.8, marking a year-over-year decrease of 2044.69%. This contributed to the annual value of $395265.9 for FY2024, which is 2420.5% down from last year.
  • As of Q3 2025, Avricore Health's Share-based Compensation (IS) stood at $37416.8, which was down 8490.27% from $92634.0 recorded in Q2 2025.
  • Avricore Health's Share-based Compensation (IS)'s 5-year high stood at $305717.0 during Q1 2021, with a 5-year trough of $1168.4 in Q2 2024.
  • For the 5-year period, Avricore Health's Share-based Compensation (IS) averaged around $91038.4, with its median value being $59359.9 (2021).
  • As far as peak fluctuations go, Avricore Health's Share-based Compensation (IS) plummeted by 9906.87% in 2024, and later skyrocketed by 782852.9% in 2025.
  • Quarter analysis of 5 years shows Avricore Health's Share-based Compensation (IS) stood at $7274.1 in 2021, then surged by 2361.04% to $179018.8 in 2022, then plummeted by 41.42% to $104866.0 in 2023, then grew by 18.79% to $124567.1 in 2024, then tumbled by 69.96% to $37416.8 in 2025.
  • Its Share-based Compensation (IS) stands at $37416.8 for Q3 2025, versus $92634.0 for Q2 2025 and $43111.9 for Q1 2025.